Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study

Tugal-Tutkun, Ilknur; KADAYIFÇILAR, SİBEL; Khairallah, Moncef; Lee, Sung; Ozdal, Pinar; Ozyazgan, Yilmaz; Song, Ji; Yu, Hyeong; Lehner, Valerie; de Cordoue, Agnes; Bernard, Oana; Gül, Ahmet

doi:10.3109/09273948.2015.1092558

Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study

Atıf İçin Kopyala

Tugal-Tutkun I., KADAYIFÇILAR S. , Khairallah M., Lee S. C. , Ozdal P., Ozyazgan Y., ...Daha Fazla

OCULAR IMMUNOLOGY AND INFLAMMATION, cilt.25, sa.1, ss.62-70, 2017 (SCI İndekslerine Giren Dergi)

Cilt numarası: 25 Konu: 1
Basım Tarihi: 2017
Doi Numarası: 10.3109/09273948.2015.1092558
Dergi Adı: OCULAR IMMUNOLOGY AND INFLAMMATION
Sayfa Sayıları: ss.62-70

Özet

Purpose: To evaluate the safety and efficacy of gevokizumab for the treatment of Behcet's disease uveitis in a prospective, open-label, randomized phase 2 trial.